Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives

Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives

Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to 3.8 per 100,000 people. Weakening and gradual atrophy of the voluntary muscles are the first signs of the disease ons...

Full description

Bibliographic Details
Main Authors: Shahrzad Najafi, Parizad Najafi, Najmeh Kaffash Farkhad, Ghazal Hosseini Torshizi, Reza Assaran Darban, Amir Reza Boroumand, Sajad Sahab-Negah, Mohammad Ali Khodadoust, Jalil Tavakol Afshari
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2023-08-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
amyotrophic lateral-sclerosis
clinical trial
mesenchymal stem cells
motor neurons
neurological disease
Online Access:https://ijbms.mums.ac.ir/article_22335_7cb9575036d8a3a0fdae0577babc70f4.pdf

Internet

https://ijbms.mums.ac.ir/article_22335_7cb9575036d8a3a0fdae0577babc70f4.pdf

Similar Items